Other Tests
See the list below:
-
Do not forego a skin spot test, an important step in laser hair removal. The results of skin patch testing determine the settings for the laser and the safety profile.
-
Perform testing in a low-visibility area with the same skin type as the area intended for treatment. If possible, allow 48-72 hours before reexamining the site to assess for efficacy and/or negative reactions.
-
If sufficient energy is delivered and absorbed, a generalized hyperemia reaction with mild focal swelling is visible after 3-5 minutes.
Increase the fluence for the particular skin type, and note the patient's pain reaction until the hyperemia reaction is observed.
For light or thin hair, the reaction may be minimal even at high settings.
-
Note the laser setting for each type of treated area.
Treatment & Management
Contributor Information and Disclosures
Author
Elizabeth Usedom Rogozinski, MD, MS, FAAD Medical and Cosmetic Dermatologist
Elizabeth Usedom Rogozinski, MD, MS, FAAD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery
Disclosure: Nothing to disclose.
Specialty Editor Board
Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference
Disclosure: Received salary from Medscape for employment. for: Medscape.
Dominique Dorion, MD, MSc, FRCSC, FACS Dean, Professor of Surgery, Division of Otolaryngology-Head and Neck Surgery, Faculty of Medicine, Université de Sherbrooke, Canada
Dominique Dorion, MD, MSc, FRCSC, FACS is a member of the following medical societies: Canadian Society of Otolaryngology-Head & Neck Surgery
Disclosure: Nothing to disclose.
Chief Editor
Arlen D Meyers, MD, MBA Emeritus Professor of Otolaryngology, Dentistry, and Engineering, University of Colorado School of Medicine
Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American Head and Neck Society
Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Cerescan; Neosoma; MI10;<br/>Received income in an amount equal to or greater than $250 from: Neosoma; Cyberionix (CYBX)<br/>Received ownership interest from Cerescan for consulting for: Neosoma, MI10 advisor.
Additional Contributors
Mounir Bashour, MD, PhD, CM, FRCSC, FACS Assistant Professor of Ophthalmology, McGill University Faculty of Medicine; Clinical Assistant Professor of Ophthalmology, Sherbrooke University; Medical Director, Cornea Laser and Lasik MD
Mounir Bashour, MD, PhD, CM, FRCSC, FACS is a member of the following medical societies: American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, American College of International Physicians, American College of Surgeons, American Medical Association, American Society of Cataract and Refractive Surgery, American Society of Mechanical Engineers, American Society of Ophthalmic Plastic and Reconstructive Surgery, Biomedical Engineering Society, Canadian Medical Association, Canadian Ophthalmological Society, Contact Lens Association of Ophthalmologists, International College of Surgeons US Section, Ontario Medical Association, Quebec Medical Association, Royal College of Physicians and Surgeons of Canada
Disclosure: Nothing to disclose.
Paul S Nassif, MD FACS, Consulting Surgeon, Facial Plastic and Reconstructive Surgery, Spalding Drive Cosmetic Surgery and Dermatology
Paul S Nassif, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, California Medical Association, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons
Disclosure: Nothing to disclose.
Andrea James, MA Director of HairFacts.com, Deep Stealth Productions, Inc
Disclosure: Nothing to disclose.
